Marvell delivered Q4 FY2026 revenue of $2.219B (+22% YoY), beating guidance midpoint, with non-GAAP EPS of $0.80 (beat by $0.10). Full-year FY2026 revenue reached $8.195B (+42% YoY) with non-GAAP EPS of $2.84 (+81%). Management raised FY2027 guidance to ~$11B (from $10B) and introduced a $15B FY2028 target with EPS “well over $5.” The stock surged to $86.78 after hours. One signal changed: NARRATIVE_REALITY_GAP upgraded from DIVERGING to CONVERGING as revenue reacceleration and custom pipeline conversion narrow the gap between management narrative and operational delivery. Seven other signals confirmed. Our analysis retains its overall assessment with this material signal improvement.
What Changed
The prior core thesis — revenue growth decelerating while management tone escalates — has been directly falsified. Revenue growth is reaccelerating from 22% in Q4 to a guided 27% in Q1, with acceleration expected each quarter through FY2027. FY2027 targets were raised three times in six months ($9.5B → $10B → $11B). Custom revenue hit $1.5B (doubled as guided) with 20+ sockets now in production. Both Celestial AI and XConn acquisitions closed with integration underway and CPO chiplet entering high-volume manufacturing.
Management has simultaneously escalated the narrative frontier further: $15B FY2028 revenue with EPS “well over $5.” Near-term execution validates FY2027, but the FY2028–FY2029 targets still require unprecedented multi-vector execution across custom XPU, interconnect, and CPO product lines.
What Was Confirmed (7 Signals)
DC revenue 74% of total and projected to rise to ~84% by FY2028. Product diversification within DC is expanding (7–8 distinct product lines: PAM DSP, coherent, DCI, AEC, retimer, CXL, custom XPU, CPO) but all remain tied to hyperscaler CapEx.
1.6T PAM DSP in production, 2nm coherent DCI DSP announced (industry first), system integration upgraded from “not yet demonstrated” to “emerging.” DCI modules shipping to all 5 major US hyperscalers. Broadcom remains a capable alternative across every category.
Net debt/EBITDA at 0.57x, improving. Two acquisitions absorbed without balance sheet deterioration. FY2026 capital returns totaled $2.245B (repurchases + dividends).
After-hours move to $86.78 has not fully priced in the $11B/$15B framework, suggesting the market retains healthy skepticism. The stock rose significantly on results that validated near-term execution.
Market Resolution
Prediction Updates (7 Markets)
| Market | Before | After | Shift |
|---|---|---|---|
| Gross margin < 59% FY2027 | 63% | 87% | +24pp |
| Custom 3rd program volume | 58% | 66% | +8pp |
| Broadcom competitive overlap | 38% | 28% | -10pp |
| Celestial AI revenue target | 47% | 32% | -15pp |
| DC revenue > $2B/quarter | 28% | 20% | -8pp |
| Hyperscaler CapEx decel | 6% | 4% | -2pp |
| Non-DC revenue > $600M | 33% | 30% | -3pp |
The largest shift was gross margin compression: the ensemble now assigns 87% probability that non-GAAP gross margins fall below 59% in FY2027, up from 63%. Q4 came in at 59.0% and Q1 is guided at 58.75% midpoint — the mix shift toward lower-margin custom silicon is now clearly underway. Offsetting this: five downside risk markets declined, with Celestial AI revenue risk dropping 15 points as the acquisition closed and the custom 3rd program rising 8 points on the new Tier 1 XPU confirmation.
Key Numbers
| Metric | Q4 FY2026 | FY2026 | FY2027 Guide |
|---|---|---|---|
| Revenue | $2.219B | $8.195B (+42%) | ~$11B |
| Non-GAAP EPS | $0.80 | $2.84 (+81%) | — |
| Non-GAAP Gross Margin | 59.0% | 59.5% | 58.75% (Q1) |
| DC Revenue | $1.5B (74%) | — | +40% YoY |
| Custom Revenue | — | $1.5B (2x) | >20% growth |
| Net Debt/EBITDA | 0.57x | — | — |
FY2028 targets: ~$15B revenue, non-GAAP EPS “well over $5,” Q4 FY2027 exit rate above $3B quarterly. Interconnect growth raised from 30% to 50%+. Switches guided above $600M in FY2027 (up from $500M). XPU attach revenue heading from ~$200M to ~$1B by FY2028.
What to Watch
The CONVERGING classification is inherently fragile. A single material miss would reverse the assessment back to DIVERGING. The market's move to $86.78 reflects partial validation, not full acceptance of the $11B/$15B framework.
- Q1 FY2027 (June 2026): Revenue guided $2.4B midpoint (+27% YoY). A miss below $2.28B (5% below guide) would reverse the CONVERGING assessment immediately. This is the most important near-term data point.
- Gross margin trajectory: Q1 guided 58.25%–59.25%. Two consecutive quarters below 58% would trigger escalation across EXPECTATIONS_PRICED and COMPETITIVE_POSITION signals. The ensemble now assigns 87% probability to sub-59% for FY2027.
- Custom silicon 3rd program: CEO expressed high confidence in new Tier 1 XPU customer (“Do you see me blinking? You do not.”). Firm volume requirements for FY2028. At 66% probability, the ensemble sees this as more likely than not. Failure here would challenge the $15B FY2028 target.
- Celestial AI milestones (H2 FY2028): $500M ARR target reaffirmed. First commercial CPO deployment confirmed for FY2028. This is the earliest point where the acquisition thesis can be validated.
- Hyperscaler CapEx persistence: The master variable. Cloud CapEx expectations “continued to increase” since December, and bookings are “accelerating at record pace.” At 4% probability for deceleration below 15%, the ensemble views this as a tail risk — but it remains the single factor that conditions everything else.